Evidence map›Paper›PMID 20007529›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens.

Chao Jiang, Umesh S Deshmukh, Felicia Gaskin, Harini Bagavant, Julie Hanson, Chella S David, Shu Man Fu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Chao JiangDivision of Rheumatology and Immunology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Umesh S Deshmukh
Felicia Gaskin
Harini Bagavant
Julie Hanson
Chella S David
Shu Man Fu
Mayo Clinic in Arizona · USCenter for Neuroscience and Regenerative Medicine · USCenter for Rheumatology · USCzech Academy of Sciences, Institute of Microbiology · CZImmunité et Cancer · FRUniversity of Virginia · US

Funding

SPECIALIZED CENTER OF RESEARCH ON SYSTEMIC LUPUS ERYTHEMP50AR045222 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 1998 to 2006
$7.9M
IMMUNOGENETICS OF COLLAGEN-INDUCED ARTHRITIS IN MICER01AR030752 · NIAMS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S, TANEJA, VEENA · 1987 to 2014
$4.3M
HLA-D Region Systemic Lupus Erythematosus PathogenesisR01AR049449 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 2005 to 2015
$4.2M
Genetics of Autontibody DiversificationK01AR051391 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI DESHMUKH, UMESH S · 2004 to 2008
$499k
Regulatory T cells in Systemic Lupus ErythematosusK01DK063065 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BAGAVANT, HARINI · 2003 to 2007
$496k
IMMUNE RESPONSES TO AUTOANTIGENS IN THE INDUCTION OF SLER01AI043248 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 1997 to 2001
$477k
NIAID NIH HHS R01 AI043248NIAID NIH HHS R01-AI043248NIAMS NIH HHS K01 AR051391NIAMS NIH HHS K01-AR051391NIAMS NIH HHS P50 AR045222NIAMS NIH HHS P50-AR045222NIAMS NIH HHS R01 AR030752NIAMS NIH HHS R01 AR049449NIAMS NIH HHS R01-AR049449NIAMS NIH HHS R01-AR30752NIDDK NIH HHS K01 DK063065NIDDK NIH HHS K01-DK063065
6 · The paper itself

Abstract

Anti-Smith (Sm) D autoantibodies are specific for systemic lupus erythematosus. In this investigation, the influence of HLA-D genes on immune responses to SmD was investigated. Mice with HLA-DR3, HLA-DR4, HLA-DQ0601, HLA-DQ0604, or HLA-DQ8 transgenes were immunized with recombinant SmD1, and their Ab responses were analyzed. Analysis by ELISA showed that all strains responded well to SmD. However, when synthetic SmD peptides were used as substrate, DR3 mice had the highest Ab response followed by DQ8, DQ0604, DQ0601, and DR4. A similar trend was observed in Western blot analysis using WEHI 7.1 cell lysate as the substrate, with the exception that DR4 mice did not generate detectable amounts of Abs. Only sera from DR3 and DQ0604 mice immunoprecipitated A-ribonucleoprotein (RNP), SmB, and SmD. Intermolecular epitope spreading to A-RNP and SmB was evident in DR3 and DQ0604 mice, as sera depleted of anti-SmD Abs were reactive with these proteins. DR3 mice also generated an immune response to C-RNP. Anti-nuclear Abs were detected in the majority of the DR3 mice, whereas moderate reactivities were seen in DQ0604 and DQ8 mice. Interestingly, only DR3 mice mounted an anti-dsDNA Ab response. Approximately half of the anti-dsDNA Abs were cross-reactive with SmD. Ab responses correlated with the strength of the T cell responses. Thus, HLA-DR3 appears to be the dominant HLA-D gene that determines the magnitude and quality of the anti-SmD immune response. In addition, our findings provide insights into the origin of the anti-dsDNA Abs often detected in patients with systemic lupus erythematosus.

Indexed as

AnimalsAntibody DiversityAntigens, NuclearAutoantibodiesAutoantigensAutoimmunityDNAHLA-DQ AntigensHLA-DR3 AntigenHLA-DR AntigensLupus Erythematosus, SystemicMiceMice, TransgenicRibonucleoproteins, Small NuclearsnRNP Core ProteinsAntigens, NuclearAutoantibodiesAutoantigensDNAHLA-DQ AntigensHLA-DR3 AntigenHLA-DR AntigensRibonucleoproteins, Small NuclearsnRNP Core ProteinsSnrpd1 protein, mouse

Identifiers

PMID20007529
PMCPMC2842881
OpenAlexW1950522893

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.